A detailed history of Big Sur Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Big Sur Wealth Management LLC holds 3,301 shares of ABBV stock, worth $563,381. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,301
Previous 3,301 -0.0%
Holding current value
$563,381
Previous $651,000 9.98%
% of portfolio
0.17%
Previous 0.18%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $41,948 - $48,985
-271 Reduced 7.59%
3,301 $566,000
Q1 2024

May 21, 2024

SELL
$159.82 - $182.1 $673,161 - $767,005
-4,212 Reduced 54.11%
3,572 $650,000
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $106,640 - $120,101
-775 Reduced 9.05%
7,784 $1.21 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $86,833 - $100,522
-650 Reduced 7.06%
8,559 $1.28 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $139,268 - $173,309
-1,051 Reduced 10.24%
9,209 $1.24 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $289,220 - $333,080
2,000 Added 24.21%
10,260 $1.64 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $447,847 - $537,087
-3,238 Reduced 28.16%
8,260 $1.34 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $113,139 - $129,762
-843 Reduced 6.83%
11,498 $1.54 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $60,690 - $77,157
441 Added 3.71%
12,341 $1.89 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $92,386 - $114,625
700 Added 6.25%
11,900 $1.93 Million
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $967,932 - $1.08 Million
9,200 Added 460.0%
11,200 $1.26 Million
Q4 2020

Jan 22, 2021

BUY
$80.49 - $108.67 $160,980 - $217,340
2,000 New
2,000 $214,000
Q1 2019

Apr 05, 2019

SELL
$77.14 - $90.79 $185,136 - $217,896
-2,400 Closed
0 $0
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $167,640 - $214,128
2,400
2,400 $213,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Big Sur Wealth Management LLC Portfolio

Follow Big Sur Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Big Sur Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Big Sur Wealth Management LLC with notifications on news.